Intelligent Concurrent MRSI and fMRI System
Legal Citation
Summary of the Inventive Concept
A novel system integrating Magnetic Resonance Spectroscopic Imaging (MRSI) and functional Magnetic Resonance Imaging (fMRI) with AI, IoT, blockchain, nanomaterials, quantum computing, and 5G technologies to provide a comprehensive brain health assessment, accurate diagnosis, and real-time analysis.
Background and Problem Solved
The original patent, 'Concurrent MRSI and fMRI', addressed the limitation of long scan times in MRSI and fMRI data acquisition. However, the new inventive concept tackles the additional challenges of data processing, storage, and transmission, as well as the need for accurate diagnosis and real-time analysis, by synergistically combining MRSI and fMRI with emerging technologies.
Detailed Description of the Inventive Concept
The Intelligent Concurrent MRSI and fMRI System comprises an MRI scanner, an AI-driven image processing module, a blockchain-based data storage system, IoT-enabled sensors, a nanomaterial-based contrast agent, a computer-aided diagnosis module, a quantum computing-based algorithm, and a 5G-enabled data transmission module. The AI-driven image processing module integrates MRSI and fMRI data to provide a comprehensive brain health assessment. The blockchain-based data storage system ensures secure and decentralized data management. The IoT-enabled sensors track brain activity, and the machine learning algorithms identify patterns indicative of brain disorders. The nanomaterial-based contrast agent enhances MRSI and fMRI signal quality. The computer-aided diagnosis module provides an accurate diagnosis of brain disorders. The quantum computing-based algorithm accelerates MRSI and fMRI data processing, providing high-resolution images of brain activity. The 5G-enabled data transmission module enables rapid data transmission, and the cloud-based data analytics platform provides real-time analysis of MRSI and fMRI data.
Novelty and Inventive Step
The new claims introduce the novel combination of MRSI and fMRI with AI, IoT, blockchain, nanomaterials, quantum computing, and 5G technologies, which is non-obvious and provides a significant improvement over the original patent. The synergistic integration of these technologies enables a comprehensive brain health assessment, accurate diagnosis, and real-time analysis, which is not achievable by the original patent alone.
Alternative Embodiments and Variations
Alternative embodiments of the Intelligent Concurrent MRSI and fMRI System could include using different AI algorithms, varying the type of IoT-enabled sensors, or incorporating other emerging technologies such as augmented reality or biometrics. Variations of the system could be tailored to specific applications, such as sports medicine or neurosurgical planning.
Potential Commercial Applications and Market
The Intelligent Concurrent MRSI and fMRI System has significant commercial potential in the healthcare industry, particularly in neuroimaging, neurology, and psychiatry. The system could be marketed to hospitals, research institutions, and pharmaceutical companies, and could also be used in sports medicine, neurosurgical planning, and other fields.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Imaging and Diagnostic Technologies, specifically Magnetic Resonance Imaging (MRI) techniques with expertise in spectroscopic and functional neuroimaging
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical imaging specialist with advanced knowledge of MRI technologies, signal processing, computational methods, and interdisciplinary medical diagnostic techniques
Obviousness Rationale
A PHOSITA would recognize that integrating advanced computational and communication technologies with existing MRSI and fMRI techniques represents a natural progression of medical imaging innovation. The proposed variations leverage well-established technological domains to enhance existing imaging methodologies. The incremental improvements in data processing, transmission, and analysis would be considered predictable extensions of known medical imaging research strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,306 |
|---|---|
| Title | Concurrent MRSI and fMRI |
| Assignee(s) | UNM RAINFOREST INNOVATIONS |